文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

放疗前是否需要准备?一项关于在前列腺图像引导外照射放疗肠道准备中使用抗胀气药物的随机试验

To prep or not to prep - that is the question: A randomized trial on the use of antiflatulent medication as part of bowel preparation for patients having image guided external beam radiation therapy to the prostate.
PubMed 文献 · Pract Radiat Oncol · 2017-11-04

该随机试验纳入78例接受根治性前列腺/瘤床放疗的患者,等量分配至抗胀气药物干预组或对照组。未报告2级以上急性直肠毒性。结论认为加用抗胀气药物未影响CT模拟重扫频率,标准化肠道准备教育可能足以限制直肠大小变化。

要点

  • 未报告2级以上急性直肠毒性。

核心结论

  • 加用抗胀气药物未影响CT模拟重扫频率。
  • 时间和分组与时间交互效应对直肠直径有统计学显著影响,但均无临床显著性。
  • 为本研究制定的标准化肠道准备教育可能足以限制直肠大小变化。

研究设计与样本

  • 前瞻性随机试验,纳入接受根治性前列腺/瘤床放疗的患者。
  • 参与者随机分配至抗胀气药物干预组或对照组(无药物)。
  • 共78例患者参与,每组等量分配。
  • 记录CT模拟重扫次数,在CT模拟和治疗锥形束CT上测量直肠直径。
  • 使用NCI CTCAE 4.0版在基线和每周评估急性直肠毒性。

主要发现

  • 未报告2级以上急性直肠毒性。

临床怎么用

  • 抗胀气药物不应常规用于减少CT模拟重扫或直肠直径变化。
  • 标准化肠道准备教育可能足以限制直肠大小变化。
  • 仍需关注时间因素对直肠直径的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Radiation therapy is a standard treatment option for prostate cancer. With growing use of escalated doses and tighter margins, procedures to limit rectal size variation are needed to reduce prostate motion, increase treatment accuracy, and minimize rectal toxicity. This prospective study was done to determine whether the introduction of an antiflatulent medication would decrease rectal distention at computed tomography (CT) simulation and throughout a course of radiation therapy. METHODS AND MATERIALS: Patients undergoing a radical course of radiation therapy to the prostate/prostate bed were eligible to participate. Participants were randomly assigned to the intervention arm (antiflatulent medication) or the control arm (no medication). For each participant, the number of CT simulation rescans was recorded. Rectal diameters were measured on CT simulation and treatment cone beam CT scans. Acute rectal toxicities were assessed at baseline and weekly using National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE), version 4.0. A χ2 analysis was used to compare the number of participants requiring a rescan in each study arm. Change in rectal diameter over time was assessed using repeated measures analysis of variance. RESULTS: A total of 78 patients participated, with equal numbers assigned to each study arm. There was no significant difference between arms in the number of participants requiring a CT simulation rescan (P = .5551). There was no significant variation in rectal diameter between arms (P = .8999); however, there was a significant effect of time (P = .0017) and a significant interaction effect between study arm and time on rectal diameter (P = .0141). No acute rectal toxicities above grade 2 were reported. CONCLUSIONS: The addition of antiflatulent medication did not affect the frequency of CT simulation rescans. Both time and the interaction between study arm and time had a statistically significant effect on rectal diameter, although neither finding was clinically significant. Instead, standardized bowel preparation education developed for this study may have been sufficient to limit rectal size variation.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. McGuffin M, Devji N, Kehoe L, et al. To prep or not to prep - that is the question: A randomized trial on the use of antiflatulent medication as part of bowel preparation for patients having image guided external beam radiation therapy to the prostate. Pract Radiat Oncol. 2017. PMID: 29329996. doi:10.1016/j.prro.2017.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。